NovaCurie AG
ActiveLimited or Corporation721001 - Research and experimental development in the pharmaceutical industry
Pharmaceutical and Medical Technology / BiotechnologyPatients with malignant brain tumors (glioblastoma)
NovaCurie AG is a Swiss AG registered in Bern, BE. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Officers6Active Relations6Deleted Relations0SOGC Records10First Record18.12.2012Latest Activity03.09.2024BiotechnologyOncologyGlioblastoma treatmentMedical TechnologyAlpha-particle therapyStart-up
Registry Information
c/o address
- Swiss UID
- CHE-367.566.035
- Legal Name
- NovaCurie AG
- Legal Form
- Limited or corporation
- Incorporated
- 18 Dec 2012
- Share Capital
- CHF 540'000.00
- Canton
- BE
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
c/o Prof. Dr. Adrian Merlo
3011, Bern, BE
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients with malignant brain tumors (glioblastoma)
